Synthesis and biodistribution of a Lipophilic 64Cu-labeled monocationic Copper(II) complex

Area of Science:

• Radiopharmaceutical Chemistry
• Nuclear Medicine
• Molecular Imaging

Background:

• Copper complexes offer unique properties for radiolabeling.
• Multidrug resistance (MDR) and myocardial perfusion are critical areas in medical diagnostics.
• Developing novel imaging agents is essential for improved patient outcomes.

Purpose of the Study:

• To synthesize and characterize a novel lipophilic, monocationic copper(II) complex.
• To evaluate the biological properties of the 64Cu-labeled complex in vitro and in vivo.
• To explore its potential as a positron emission tomography (PET) radiopharmaceutical.

Main Methods:

• Synthesis of a diiminedioxime copper(II) complex and radiolabeling with 64Cu.
• In vitro studies using MES-SA tumor cells (multidrug resistant and non-resistant).
• In vivo studies to assess biodistribution and uptake in animal models.

Main Results:

• The 64Cu-labeled complex demonstrated significant uptake in the heart, comparable to 99mTc-tetrofosmin.
• In vitro studies showed parallel uptake in multidrug resistant and non-resistant tumor cells, similar to 99mTc-MIBI.
• The complex exhibits favorable characteristics for potential PET imaging applications.

Conclusions:

• The novel 64Cu-labeled copper complex shows promise for myocardial perfusion imaging.
• Its uptake characteristics suggest potential for functional imaging of multidrug resistance.
• This class of copper complexes may serve as a basis for developing new 64Cu PET radiopharmaceuticals.